ArticleClinical pharmacology : advances and applications2018

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells.

Maha S Al-Keilani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.